Ana Galarraga AiestaranObesitatearen Ikerketarako Europako Elkarteak (EASO) obesitateari aurre egiteko algoritmoa aurkeztu du. Tresna horren barruan, protagonismo nabarmena dute tirzepatidak (Mounjaro) eta semaglutidak (Ozempic)
👉 EASOren iragarpena: https://easo.org/framework-for-the-pharmacological-treatment-of-obesity-and-its-complications-from-the-european-association-for-the-study-of-obesity/
👉 Artikulu zientifikoa: https://www.nature.com/articles/s41591-025-03765-w
#obesitatea #klinika #farmazia #algoritmo
👉 EASOren iragarpena: https://easo.org/framework-for-the-pharmacological-treatment-of-obesity-and-its-complications-from-the-european-association-for-the-study-of-obesity/
👉 Artikulu zientifikoa: https://www.nature.com/articles/s41591-025-03765-w
#obesitatea #klinika #farmazia #algoritmo
Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity - EASO
EASO Medication Management Algorithm for Obesity: Personalising Obesity Medication Management Obesity is a chronic, relapsing disease with far-reaching consequences for individual health and society. In addition to being a chronic disease in its own right, requiring sustained, personalised management and care, obesity is also a gateway to the many complications it drives, ranging from mechanical […]
